http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-S5697268-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_39ae96c0ecc22ff90ff986371a3cea0f
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P13-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D209-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-404
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D263-58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-428
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-403
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-425
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D277-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-423
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P15-00
filingDate 1980-06-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d4f6e69a3a4d6e5f46ed386716a20791
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9c4cc284f77c85c005f28bef8f1d5a0e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b070d60eda3151677fb148b2c0399ffc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a585cd6259ac332635b157bc1352a0a1
publicationDate 1981-08-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-S5697268-A
titleOfInvention Lower alkanoic acid derivative, salt and preparation thereof and preventing agent and remedy for diabetic complication containing the same as active constituent
abstract NEW MATERIAL:A lower alkanoic acid derivative expressed by formula I (R a 1 is hydroxy, halogen, nitro, amino, 3W8C cycloalkyl aryl or aryloxy which may be substituted by halogen; R 2 is H, halogen or lower alkyl; R 3 is carboxyl or protected carboxyl; Y a is S, O or CH 2 ; A is lower alkylene, however, R a 1 is a group other than halogen when R 2 is H and Y a is S or O) and a pharmaceutically acceptable salt thereof. n EXAMPLE: 2-Oxo-5,6-dichloro-3-benzothiazolineacetic acid. n USE: A preventing agent and remedy for diabetic complication, e.g. diabetic cataract, neuropathy, retinopathy and renopathy. n PROCESS: A compound of formula II or a salt thereof is reacted with a compound of formula III X 1 -A-R 3 (X 1 is acid residue) or a salt thereof. n COPYRIGHT: (C)1981,JPO&Japio
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-8501289-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2017501174-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-S62246587-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2006522041-A
priorityDate 1979-12-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397310
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397365
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID236328432
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID13097121
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421333860

Total number of triples: 38.